SDS

Date Printed: 7/30/2015
(drowsiness, dizziness, nausea, headaches, paralysis, and blurred vision) and/or damage. Reports have associated repeated and
prolonged occupational overexposure to solvents with permanent brain and nervous system damage. Contains carbon black.
Chronic inflammation, lung fibrosis, and lung tumors have been observed in some rats experimentally exposed for long periods of
time to excessive concentrations of carbon black and several insoluble fine dust particles. Tumors have not been observed in other
animal species (i.e., mouse and hamster) under similar circumstances and study conditions. Epidemiological studies of North
American workers show no evidence of clinically significant adverse health effects due to occupational exposure to carbon black.
Carbon black is listed as a Group 2B-"Possibly carcinogenic to humans" by IARC and is proposed to be listed as A4- "not classified
as a human carcinogen" by the American Conference of Governmental Industrial Hygienists. Significant exposure is not anticipated
during brush application or drying. Risk of overexposure depends on duration and level of exposure to dust from repeated sanding of
surfaces or spray mist and the actual concentration of carbon black in the formula. Contains Titanium Dioxide. Titanium Dioxide is
listed as a Group 2B-"Possibly carcinogenic to humans" by IARC. No significant exposure to Titanium Dioxide is thought to occur
during the use of products in which Titanium Dioxide is bound to other materials, such as in paints during brush application or drying.
Risk of overexposure depends on duration and level of exposure to dust from repeated sanding of surfaces or spray mist and the
actual concentration of Titanium Dioxide in the formula. (Ref: IARC Monograph, Vol. 93, 2010)
PRIMARY ROUTE(S) OF ENTRY: Eye Contact, Ingestion, Inhalation, Skin Absorption, Skin Contact
ACUTE TOXICITY VALUES
The acute effects of this product have not been tested. Data on individual components are tabulated below:
CAS-No.
Chemical Name Oral LD50 Dermal LD50 Vapor LC50
13463-67-7 Titanium Dioxide >10000 mg/kg Rat N.I. N.I.
5131-66-8 Propylene Glycol Monobutyl Ether 1900 mg/kg Rat N.I. N.I.
6846-50-0 2,2,4-Trimethyl-1,3-Pentanediol Diisobutyrate >3200 mg/kg Rat N.I. N.I.
7631-86-9 Amorphous Silica >5000 mg/kg Rat >2000 mg/kg Rabbit >2.2 mg/L Rat
1336-21-6 Aqueous Ammonia 350 mg/kg Rat N.I. N.I.
N.I. - No Information
12. Ecological Information
ECOLOGICAL INFORMATION: Product is a mixture of listed components.
13. Disposal Information
DISPOSAL INFORMATION: Dispose of material in accordance to local, state, and federal regulations and ordinances. Do not allow
to enter waterways, wastewater, soil, storm drains or sewer systems.
14. Transport Information
Domestic (USDOT) International (IMDG) Air (IATA) TDG (Canada)
UN Number: N.A. N.A. N.A. N.A.
Proper Shipping Name: Not Regulated Not Regulated Not Regulated Not Regulated
Hazard Class: N.A. N.A. N.A. N.A.
Packing Group: N.A. N.A. N.A. N.A.
Limited Quantity: No No No No
15. Regulatory Information
U.S. Federal Regulations:
CERCLA - SARA Hazard Category
This product has been reviewed according to the EPA ‘Hazard Categories’ promulgated under Sections 311 and 312 of the
Superfund Amendment and Reauthorization Act of 1986 (SARA Title III) and is considered, under applicable definitions, to
meet the following categories:
Fire Hazard, Pressure Hazard, Reactive Hazard, Acute Health Hazard, Chronic Health Hazard
Sara Section 313:
This product contains the following substances subject to the reporting requirements of Section 313 of Title III of the
Superfund Amendment and Reauthorization Act of 1986 and 40 CFR part 372:
Page 4 / 5